Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo–purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group

Mantle cell lymphoma (MCL) is considered incurable. Intensive immunochemotherapy with stem cell support has not been tested in large, prospective series. In the 2nd Nordic MCL trial, we treated 160 consecutive, untreated patients younger than 66 years in a phase 2 protocol with dose-intensified indu...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Geisler, Christian H., Kolstad, Arne, Laurell, Anna, Andersen, Niels S., Pedersen, Lone B., Jerkeman, Mats, Eriksson, Mikael, Nordström, Marie, Kimby, Eva, Boesen, Anne Marie, Kuittinen, Outi, Lauritzsen, Grete F., Nilsson-Ehle, Herman, Ralfkiær, Elisabeth, Åkerman, Måns, Ehinger, Mats, Sundström, Christer, Langholm, Ruth, Delabie, Jan, Karjalainen-Lindsberg, Marja-Liisa, Brown, Peter, Elonen, Erkki
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society of Hematology 2008
Gaiak:
Clinical Trials and Observations
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2556606/
https://ncbi.nlm.nih.gov/pubmed/18625886
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2008-03-147025
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak